The U.S. Department of Defense (DOD) Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) awarded Johns Hopkins researchers $35 million for clinical trials to test a convalescent blood plasma outpatient treatment to fight COVID-19.
{iframe}https://homelandprepnews.com/stories/53294-johns-hopkins-researchers-get-35m-grant-to-test-covid-19-outpatient-treatment/{/iframe}